The effect of epsilon-aminocaproic acid (EACA) on experimental immune nephritis.
The EACA, known for its antihemorrhagic potential, has also been demonstrated to mitigate physiopathologic reactions linked activation of serum proteolytic cascades. Herein, we present results of experiments exploring a possible modification of nephrotoxic serum nephritis (NSN) in rats by the EACA. A combined intraperitoneal and oral administration of EACA to Lewis rats with the NSN (1 g/kg/12 h and 1 g/kg/24 h, respectively), significantly reduced albuminuria (p less than 0.05 EACA-treated rats vs. rats obtaining vehicle alone, days 2-3), enhanced endogenous creatinine clearance (ECC) - (p less than 0.01 - day 3) and attenuated renal histopathologic changes (day 3 post induction). The EACA given to control healthy rats did not cause any notable changes in the above parameters. We conclude that the EACA considerably diminishes the intensity of acute nephritis induced in rats by a nephrotoxic heteroantiserum.
Kuźniar
J
J
Department of Nephrology, Academy and Medicine, Wrocław.
Hruby
Z
Z
Szewczyk
Z
Z
Rabczyński
J
J
D000419:Albuminuria / Q000188:drug therapy; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003404:Creatinine / Q000652:urine; D007678:Kidney Glomerulus / Q000473:pathology; D008297:Male; D009393:Nephritis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D011480:Protease Inhibitors / Q000627:therapeutic use; D051381:Rats; D011917:Rats, Inbred Lew
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011480:Protease Inhibitors; D003404:Creatinine; D015119:Aminocaproic Acid